Merck and Moderna received the EMA's PRIME program designation for the personalized mRNA cancer vaccine, the KEYTRUDA combination vaccine for adjuvant treatment of high-risk melanoma

Published Date: 10 Apr 2023

Melanoma, the most serious form of skin cancer, is characterized by the uncontrolled growth of pigment-producing cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

GuCS Future Focus: Future Focus from the Genitourinary Cancers Symposium

2.

The main subject is associated with suicide in the United States.

3.

Alkem introduces cetuximab under the trade name Cetuxa in India.

4.

Firefighters who eat better can combat cancer.

5.

How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot